Added value of using gene expression signature test Mammaprint for adjuvant chemotherapy decision-making in early breast cancer
Added value of using gene expression signature test Mammaprint for adjuvant chemotherapy decision-making in early breast cancer
Country | Agency | Year work was carried out | Link | Details of use |
---|---|---|---|---|
Austria | LBI-HTA | http://eprints.hta.lbg.ac.at/1147/1/HTA-Projektbericht_Nr.102.pdf | Dissemination to decision makers. | |
Austria | GOEG | 2018 | National adaptation. Made no changes to the EUnetHTA report, added a German summary. | |
Belgium | KCE | 2018 | https://kce.fgov.be/en/mammaprint®-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast | National adaptation. Added local information. |
Croatia | AAZ | Ongoing | Dissemination – prepared the Summary and assessment elements B0001 and A0020 in Croatian (will be published on the AAZ website along with links to the full EUnetHTA assessment). | |
France | HAS | 2019 | https://www.has-sante.fr/portail/jcms/c_2748998/fr/utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-de-stade-precoce-rapport-d-evaluation | National adaptation. Added local information. |
Italy | ASSR RER | Ongoing | Dissemination of the EUnetHTA report will be carried out through our website: news of publication and link; summary and results provided. | |
Italy | AGENAS | 2018 | National adaptation. Added local information. | |
Netherlands | ZIN | Ongoing | National adaptation. Added local information. | |
Norway | NIPHNO | Ongoing | National adaptation. | |
Slovakia | UNIBA | 2018 | National adaptation. Added local information. | |
Spain | OSTEBA | 2018 | The OTCA04 assessment was disseminated among the coordinators of the Breast Cancer Screening Program, among gynaecologists and among relevant decision makers. | |
Spain | AQUAS | Ongoing | The OTCA04 assessment will be disseminated to Catalan regional decision makers (physicians societies, director of corresponding plan, and Health Services Planners). | |
UK | NICE | 2018 | https://www.evidence.nhs.uk/search?q=EUnetHTA | This was originally assessed in DG10 https://www.nice.org.uk/guidance/dg10 It is currently being updated as part of guidance on a broader topic area. The HTA to inform the update was published before the EUnetHTA assessment was available. EUnetHTA reports are indexed in NHS evidence a database managed by NICE that supports evidence. |